XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ 128,700 $ (247,273)
Adjustments to reconcile net income (loss) to net cash provided by operating activities    
Depreciation, depletion, amortization and accretion expense 232,072 231,940
Amortization of deferred financing costs and original issue discount 6,952 6,934
Equity-based compensation expense 7,367 5,681
Price risk management activities expense 345,313 324,125
Net cash paid on settled derivative instruments (287,321) (117,618)
Equity method investment income (13,608) 0
Loss on extinguishment of debt   13,225
Settlement of asset retirement obligations (39,768) (36,329)
Loss (gain) on sale of assets 390 (853)
Changes in operating assets and liabilities:    
Accounts receivable (57,394) (12,633)
Other current assets (31,435) (19,409)
Accounts payable 23,360 3,776
Other current liabilities 33,284 48,597
Other non-current assets and liabilities, net 6,453 (1,069)
Net cash provided by operating activities 354,365 199,094
Cash flows from investing activities:    
Exploration, development and other capital expenditures (128,082) (125,846)
Cash paid for acquisitions, net of cash acquired (3,500) (5,399)
Proceeds from sale of property and equipment, net 1,597 4,612
Contributions to equity method investees (2,250) 0
Proceeds from sale of equity method investment 15,000 0
Net cash used in investing activities (117,235) (126,633)
Cash flows from financing activities:    
Issuance of senior notes 0 600,500
Redemption of senior notes and other long-term debt (6,060) (356,803)
Proceeds from Bank Credit Facility 35,000 0
Repayment of Bank Credit Facility (210,000) (240,000)
Deferred financing costs (129) (25,981)
Other deferred payments   (5,575)
Payments of finance lease (12,836) (10,361)
Employee stock awards tax withholdings (4,476) (3,120)
Net cash used in financing activities (198,501) (41,340)
Net increase in cash and cash equivalents 38,629 31,121
Cash and cash equivalents:    
Balance, beginning of period 69,852 34,233
Balance, end of period 108,481 65,354
Supplemental non-cash transactions:    
Capital expenditures included in accounts payable and accrued liabilities 47,354 95,724
Supplemental cash flow information:    
Interest paid, net of amounts capitalized $ 47,570 $ 19,006